NASDAQ:ADIL
Adial Pharmaceuticals Inc. Stock Company Profile
$1.41
-0.0100 (-0.704%)
At Close: May 16, 2024
Information
1180 Seminole Trail, Suite 495
Charlottesville VA 22901
434 422 9800
www.adialpharma.com
Industry: Biotechnology
Sector: Healthcare
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
